LobbyingUnited Therapeutics lobbying by quarter
United Therapeutics UTHR's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $220K. Its first report covers Q3 2025; the issues it reports most are Health Issues and Postal.
United TherapeuticsUTHR
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $220K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $20K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $80K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$160K · 2 reports
- Postal$60K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tiber Creek Group | $240K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Tiber Creek Group | $80K |
| 04/19for Q1 | Tiber Creek Group | $80K |
| 01/17for Q4 2025 | Tiber Creek Group | $60K |
| 25/10/19for Q3 2025 | Tiber Creek Group | $20K |
| 25/10/16for Q3 2025 | Tiber Creek Group | Under $5,000 |